Opendata, web and dolomites

NANOFLOWSIZER

Developing a disruptive and revolutionary tool for real time inline nanoparticle size measurement, for superior quality control and process efficiency.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NANOFLOWSIZER project word cloud

Explore the words cloud of the NANOFLOWSIZER project. It provides you a very rough idea of what is the project "NANOFLOWSIZER" about.

2020    revenue    efficacy    pfizer    safety    industrial    netherlands    chemical    turbid    instrument    skilled    manufacturers    2m    worth    274m    interferometry    founded    ps    goods    65    nfs    former    valuable    poor    measuring    quality    5m    consumers    speed    time    size    stage       drugs    nano    rate    prototype    event    sampling    global    particle    market    tools    requiring    dls    batch    batches    2017    50    billion    food    flowing    employees    pharmaceutical    lsp    drawbacks    date    eliminating    big    np    merck    inflow    teva    integrity    scattering    defective    beverage    compromises    tool    coherence    inprocess    impractical    risk    nanotechnology    industries    attracted    offline    psd    gives    light    academia    msd    nps    costing    ge    determinant    exposes    companies    rejected    suspensions    discarded    dynamic    regulator    optimisation    continuous    inline    99    rejection    nanoflowsizer    samples    remote   

Project "NANOFLOWSIZER" data sheet

The following table provides information about the project.

Coordinator
INPROCESS-LSP BV 

Organization address
address: KLOOSTERSTRAAT 9
city: OSS
postcode: 5349 AB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INPROCESS-LSP BV NL (OSS) coordinator 50˙000.00

Map

 Project objective

Nanotechnology is rapidly growing in the pharmaceutical, chemical, food & beverage industries. The global market for Nano-based goods will reach €65 Billion by 2020. A regulator of growth is quality control of Nano particle (NP) size (PS) and size distribution (PSD). The size of NPs is a determinant of their properties e.g. a change in the NP size affects the efficacy and safety of drugs. Thus, the market for NP size measurement tools is rapidly growing and in 2017 was worth €274M. To date, there is no instrument able to measure NP PS and PSD inflow. Size measurement is done offline using Dynamic Light scattering (DLS) - requiring product sampling which is often impractical as it compromises the integrity of samples. DLS systems cannot measure NP size in turbid flowing suspensions and therefore, gives measurements after batches have been produced. Defective batches are discarded costing manufacturers €0.2-2M per event with ≥50% of all batches rejected. Poor quality control exposes consumers to increased risk. There is a need for NP size measurement tools able to measure NP suspensions inflow. InProcess-LSP was founded by highly skilled former employees of MSD/Merck in Netherlands. InProcess-LSP has developed the Nanoflowsizer (NFS) a novel instrument capable of real time, inline measurement of NP PS and PSD using Low Coherence Interferometry. The NFS will provide a remote measuring tool for continuous quality control. It will achieve a 0% batch rejection rate increasing quality processing speed by 99% eliminating the drawbacks of sampling. Manufacturers will have greater control and valuable insight for process optimisation. The advanced stage of development the prototype has attracted big pharmaceutical companies including Teva and Pfizer who are our industrial partners. Target users also include NP-based manufacturers in the food and beverage and in academia. The NFS project will achieve a revenue of €4.5M by 2020 and 20 new employees.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOFLOWSIZER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOFLOWSIZER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More